| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 4.37B | 4.40B | 7.63B | 8.44B | 6.82B | 5.44B |
| Gross Profit | 2.25B | 2.47B | 5.00B | 5.70B | 4.45B | 3.38B |
| EBITDA | 887.00M | 1.04B | 3.44B | 4.10B | 2.87B | 1.83B |
| Net Income | -96.60M | -500.00K | 1.91B | 2.24B | 1.29B | 349.40M |
Balance Sheet | ||||||
| Total Assets | 14.33B | 15.37B | 15.87B | 16.37B | 16.20B | 16.48B |
| Cash, Cash Equivalents and Short-Term Investments | 250.70M | 771.70M | 319.70M | 234.00M | 319.40M | 282.00M |
| Total Debt | 5.40B | 5.67B | 6.03B | 6.60B | 7.85B | 9.07B |
| Total Liabilities | 7.77B | 8.30B | 9.22B | 9.86B | 10.30B | 11.14B |
| Stockholders Equity | 6.56B | 7.08B | 6.66B | 6.51B | 5.89B | 5.34B |
Cash Flow | ||||||
| Free Cash Flow | 819.90M | 772.10M | 2.61B | 3.13B | 2.47B | 1.82B |
| Operating Cash Flow | 911.00M | 898.10M | 2.89B | 3.62B | 2.84B | 1.92B |
| Investing Cash Flow | -199.40M | -287.80M | -392.10M | -599.50M | -477.70M | -173.30M |
| Financing Cash Flow | -1.05B | -158.30M | -2.41B | -3.10B | -2.33B | -1.86B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | $58.14B | 95.19 | 17.94% | 0.62% | 30.48% | 339.29% | |
67 Neutral | $59.29B | 29.34 | 21.01% | 1.79% | -6.81% | -23.16% | |
64 Neutral | $27.59B | 208.75 | 1.47% | ― | -16.13% | -81.06% | |
64 Neutral | $9.01B | 23.03 | 6.49% | 4.37% | -2.18% | -16.84% | |
64 Neutral | $30.40B | 178.65 | 0.93% | 1.28% | -17.33% | -76.71% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
58 Neutral | $41.09B | ― | -1.09% | 2.79% | -23.36% | -131.15% |
On February 9–11, 2026, Microchip Technology issued $900 million of 0% Convertible Senior Notes due 2030 in a private Rule 144A placement, generating net proceeds of about $883.3 million after fees. The notes, which are senior unsecured obligations with an initial conversion price of roughly $104.17 per share, were sold to qualified institutional buyers, with Microchip retaining the option to settle conversions in cash, stock or a mix.
The company used approximately $68 million of the proceeds to purchase capped call transactions with dealers, setting an initial cap at $148.82 per share to mitigate dilution and potential cash outlays upon conversion. Microchip plans to apply the remaining funds to repay borrowings under its commercial paper program, effectively terming out short‑term debt and fine‑tuning its capital structure while managing future equity dilution for existing shareholders.
The most recent analyst rating on (MCHP) stock is a Hold with a $69.00 price target. To see the full list of analyst forecasts on Microchip stock, see the MCHP Stock Forecast page.